106 related articles for article (PubMed ID: 21724347)
1. Association of platelet-SDF-1 with hemodynamic function and infarct size using cardiac MR in patients with AMI.
Geisler T; Fekecs L; Wurster T; Chiribiri A; Schuster A; Nagel E; Miller S; Gawaz M; Stellos K; Bigalke B
Eur J Radiol; 2012 Apr; 81(4):e486-90. PubMed ID: 21724347
[TBL] [Abstract][Full Text] [Related]
2. Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells.
Stellos K; Bigalke B; Langer H; Geisler T; Schad A; Kögel A; Pfaff F; Stakos D; Seizer P; Müller I; Htun P; Lindemann S; Gawaz M
Eur Heart J; 2009 Mar; 30(5):584-93. PubMed ID: 19109356
[TBL] [Abstract][Full Text] [Related]
3. Expression of platelet-bound stromal-cell derived factor-1 (SDF-1) and number of CD34(+) progenitor cells in patients with congestive heart failure.
Jorbenadze R; Schleicher E; Bigalke B; Stellos K; Gawaz M
Platelets; 2014; 25(6):409-15. PubMed ID: 24102302
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
5. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
[TBL] [Abstract][Full Text] [Related]
6. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY
J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serial measurements of infarct size and left ventricular ejection fraction by contrast-enhanced cardiac magnetic resonance imaging and electrocardiographic QRS scoring in reperfused anterior ST-elevation myocardial infarction.
Weir RA; Martin TN; Murphy CA; Petrie CJ; Clements S; Steedman T; Dargie HJ; Wagner GS
J Electrocardiol; 2010; 43(3):230-6. PubMed ID: 20116803
[TBL] [Abstract][Full Text] [Related]
8. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
Britten MB; Abolmaali ND; Assmus B; Lehmann R; Honold J; Schmitt J; Vogl TJ; Martin H; Schächinger V; Dimmeler S; Zeiher AM
Circulation; 2003 Nov; 108(18):2212-8. PubMed ID: 14557356
[TBL] [Abstract][Full Text] [Related]
9. Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction.
Nijveldt R; Beek AM; Hofman MB; Umans VA; Algra PR; Spreeuwenberg MD; Visser CA; van Rossum AC
J Cardiovasc Magn Reson; 2007; 9(5):765-70. PubMed ID: 17891613
[TBL] [Abstract][Full Text] [Related]
10. Impact of early, late, and no ST-segment resolution measured by continuous ST Holter monitoring on left ventricular ejection fraction and infarct size as determined by cardiovascular magnetic resonance imaging.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Majidi M; Hirsch A; Tijssen JG; Krucoff MW; De Winter RJ
J Electrocardiol; 2011; 44(1):36-41. PubMed ID: 20888008
[TBL] [Abstract][Full Text] [Related]
11. Impact of coronary artery collaterals on infarct size assessed by serial cardiac magnetic resonance imaging after primary percutaneous coronary intervention in patients with acute myocardial infarction.
Yoon SJ; Ko YG; Kim JS; Moon JY; Kim YJ; Park S; Ha JW; Choi D; Jang Y; Chung N; Shim WH; Cho SY
Coron Artery Dis; 2009 Nov; 20(7):440-5. PubMed ID: 19730371
[TBL] [Abstract][Full Text] [Related]
12. [Dynamic changes of plasma VEGF, SDF-1 and peripheral CD34+ cells in patients with acute myocardial infarction].
Deng ZR; Yang C; Ma AQ; Chen XY; Geng T
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1637-40. PubMed ID: 17121721
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
14. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
15. Platelet expression of stromal-cell-derived factor-1 (SDF-1): an indicator for ACS?
Wurster T; Stellos K; Haap M; Seizer P; Geisler T; Otton J; Indermuehle A; Ishida M; Schuster A; Nagel E; Gawaz M; Bigalke B
Int J Cardiol; 2013 Mar; 164(1):111-5. PubMed ID: 21737155
[TBL] [Abstract][Full Text] [Related]
16. Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct.
Pride YB; Giuseffi JL; Mohanavelu S; Harrigan CJ; Manning WJ; Gibson CM; Appelbaum E
Am J Cardiol; 2010 Sep; 106(5):635-40. PubMed ID: 20723637
[TBL] [Abstract][Full Text] [Related]
17. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics.
Baks T; van Geuns RJ; Biagini E; Wielopolski P; Mollet NR; Cademartiri F; van der Giessen WJ; Krestin GP; Serruys PW; Duncker DJ; de Feyter PJ
J Am Coll Cardiol; 2006 Jan; 47(1):40-4. PubMed ID: 16386662
[TBL] [Abstract][Full Text] [Related]
18. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
19. Impact of systolic and diastolic deformation indexes assessed by strain-encoded imaging to predict persistent severe myocardial dysfunction in patients after acute myocardial infarction at follow-up.
Neizel M; Korosoglou G; Lossnitzer D; Kühl H; Hoffmann R; Ocklenburg C; Giannitsis E; Osman NF; Katus HA; Steen H
J Am Coll Cardiol; 2010 Sep; 56(13):1056-62. PubMed ID: 20846606
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
